Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for Jade Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-05 4:26 pm Purchase |
2025-04-28 | 13G | Jade Biosciences, Inc. JBIO |
Venrock Healthcare Capital Partners III, L.P. | 3,220,369 9.900% |
3,220,369 (New Position) |
Filing |